A Systematic Review of Clinical Trials Assessing Sexuality in Hysterectomized Patients.
Laura Martínez-CayuelasPau Sarrio-SanzAntonio Palazón-BruLidia Verdú-VerdúAna López-LópezVicente Francisco Gil-GuillénJesús Romero-MarotoLuis Gomez-PerezPublished in: International journal of environmental research and public health (2021)
In hysterectomized patients, even though there is still controversy, evidence indicates that in the short term, the vaginal approach shows benefits over the laparoscopic approach, as it is less invasive, faster and less costly. However, the quality of sexual life has not been systematically reviewed in terms of the approach adopted. Through a systematic review, we analyzed (CRD42020158465 in PROSPERO) the impact of hysterectomy on sexual quality and whether there are differences according to the surgical procedure (abdominal or vaginal) for noncancer patients. MEDLINE (through PubMed), Embase, Cochrane Central Register of Controlled Trials, ClinicalTrials.gov and Scopus were reviewed to find randomized clinical trials assessing sexuality in noncancer patients undergoing total hysterectomy, comparing vaginal and abdominal (laparoscopic and/or open) surgery. Three studies that assessed the issue under study were finally included. Two of these had a low risk of bias (Cochrane risk of bias tool); one was unclear. There was significant variability in how sexuality was measured, with no differences between the two approaches considered in the review. In conclusion, no evidence was found to support one procedure (abdominal or vaginal) over another for non-oncological hysterectomized patients regarding benefits in terms of sexuality.
Keyphrases
- end stage renal disease
- newly diagnosed
- clinical trial
- ejection fraction
- chronic kidney disease
- peritoneal dialysis
- minimally invasive
- prognostic factors
- patients undergoing
- randomized controlled trial
- prostate cancer
- coronary artery disease
- acute coronary syndrome
- robot assisted
- atrial fibrillation
- coronary artery bypass
- study protocol
- patient reported outcomes
- phase iii